Literature DB >> 2998332

Properties of caldesmon isolated from chicken gizzard.

P K Ngai, M P Walsh.   

Abstract

Chicken gizzard smooth muscle contains two major calmodulin-binding proteins: caldesmon (11.1 microM; Mr 141 000) and myosin light-chain kinase (4.6 microM; Mr 136 000), both of which are associated with the contractile apparatus. The amino acid composition of caldesmon is distinct from that of myosin light-chain kinase and is characterized by a very high glutamic acid content (25.5%), high contents of lysine (13.6%) and arginine (10.3%), and a low aromatic amino acid content (2.4%). Caldesmon lacked myosin light-chain kinase and phosphatase activities and did not compete with either myosin light-chain kinase or cyclic nucleotide phosphodiesterase (both calmodulin-dependent enzymes) for available calmodulin, suggesting that calmodulin may have distinct binding sites for caldesmon on the one hand and myosin light-chain kinase and cyclic nucleotide phosphodiesterase on the other. Consistent with the lack of effect of caldesmon on myosin phosphorylation, caldesmon did not affect the assembly or disassembly of myosin filaments in vitro. As previously shown [Ngai & Walsh (1984) J. Biol. Chem. 259, 13656-13659], caldesmon can be reversibly phosphorylated. The phosphorylation and dephosphorylation of caldesmon were further characterized and the Ca2+/calmodulin-dependent caldesmon kinase was purified; kinase activity correlated with a protein of subunit Mr 93 000. Caldesmon was not a substrate of myosin light-chain kinase or phosphorylase kinase, both calmodulin-activated protein kinases.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998332      PMCID: PMC1152673          DOI: 10.1042/bj2300695

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

1.  Structure and function of chicken gizzard myosin.

Authors:  H Suzuki; H Onishi; K Takahashi; S Watanabe
Journal:  J Biochem       Date:  1978-12       Impact factor: 3.387

2.  Roles of calcium and phosphorylation in the regulation of the activity of gizzard myosin.

Authors:  J M Sherry; A Górecka; M O Aksoy; R Dabrowska; D J Hartshorne
Journal:  Biochemistry       Date:  1978-10-17       Impact factor: 3.162

3.  Effect of phosphorylation of smooth muscle myosin on actin activation and Ca2+ regulation.

Authors:  S Chacko; M A Conti; R S Adelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

4.  Hysteretic substrate activation of bovine heart c-AMP phosphodiestrase.

Authors:  J H Wang; T S Teo; T H Wang
Journal:  Biochem Biophys Res Commun       Date:  1972-02-16       Impact factor: 3.575

5.  The Croonian lecture, 1979: Regulation of muscle contraction.

Authors:  S Ebashi
Journal:  Proc R Soc Lond B Biol Sci       Date:  1980-03-21

6.  Bovine stomach myosin light chain kinase: purification, characterization, and comparison with the turkey gizzard enzyme.

Authors:  M P Walsh; S Hinkins; I L Flink; D J Hartshorne
Journal:  Biochemistry       Date:  1982-12-21       Impact factor: 3.162

7.  Refinement of the coomassie blue method of protein quantitation. A simple and linear spectrophotometric assay for less than or equal to 0.5 to 50 microgram of protein.

Authors:  T Spector
Journal:  Anal Biochem       Date:  1978-05       Impact factor: 3.365

8.  Complete amino acid analysis of proteins from a single hydrolysate.

Authors:  R J Simpson; M R Neuberger; T Y Liu
Journal:  J Biol Chem       Date:  1976-04-10       Impact factor: 5.157

9.  Conformational transition accompanying the binding of Ca2+ to the protein activator of 3',5'-cyclic adenosine monophosphate phosphodiesterase.

Authors:  C B Klee
Journal:  Biochemistry       Date:  1977-03-08       Impact factor: 3.162

10.  Calmodulin-binding proteins from brain and other tissues.

Authors:  R J Grand; S V Perry
Journal:  Biochem J       Date:  1979-11-01       Impact factor: 3.857

View more
  21 in total

1.  Acrylodan-labeled smooth muscle tropomyosin reports differences in the effects of troponin and caldesmon in the transition from the active state to the inactive state.

Authors:  Joseph M Chalovich; Evan Lutz; Tamatha Baxley; Mechthild M Schroeter
Journal:  Biochemistry       Date:  2011-06-14       Impact factor: 3.162

2.  A mosaic multiple-binding model for the binding of caldesmon and myosin subfragment-1 to actin.

Authors:  Y D Chen; J M Chalovich
Journal:  Biophys J       Date:  1992-10       Impact factor: 4.033

3.  The effects of phosphorylation of smooth-muscle caldesmon.

Authors:  P K Ngai; M P Walsh
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

Review 4.  The molecular anatomy of caldesmon.

Authors:  S B Marston; C S Redwood
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

5.  Intracellular calcium levels in canine basilar artery smooth muscle following experimental subarachnoid hemorrhage: an electron microscopic cytochemical study.

Authors:  K Kohno; S Sakaki; S Ohue; Y Kumon; K Matsuoka
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

6.  Ca2+ can control vascular smooth-muscle thin filaments without caldesmon phosphorylation.

Authors:  S B Marston
Journal:  Biochem J       Date:  1986-07-15       Impact factor: 3.857

7.  Reversal of caldesmon binding to myosin with calcium-calmodulin or by phosphorylating caldesmon.

Authors:  M E Hemric; F W Lu; R Shrager; J Carey; J M Chalovich
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

8.  The interaction of caldesmon with the COOH terminus of actin.

Authors:  R Crosbie; S Adams; J M Chalovich; E Reisler
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

9.  Localization and characterization of a 7.3-kDa region of caldesmon which reversibly inhibits actomyosin ATPase activity.

Authors:  J M Chalovich; J Bryan; C E Benson; L Velaz
Journal:  J Biol Chem       Date:  1992-08-15       Impact factor: 5.157

10.  Smooth-muscle caldesmon phosphatase is SMP-I, a type 2A protein phosphatase.

Authors:  M D Pato; C Sutherland; S J Winder; M P Walsh
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.